Ness-Ziona, Israel

Eli Matalon

This inventor holds 1 USPTO granted patent. Top assignee: Vascular Technologies, Inc.. Active years: 1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Eli Matalon. Retrieved from https://idiyas.com/inventor/eli-matalon

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 1.0

ph-index = 1

Forward Citations = 83(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Eli Matalon: Innovator in Vascular Technology

Introduction

Eli Matalon is a notable inventor based in Ness-Ziona, Israel. He has made significant contributions to the field of medical technology, particularly in vascular innovations. His work focuses on improving medical procedures and patient outcomes through innovative solutions.

Latest Patents

Eli Matalon holds a patent for a Blood Vessel Entry Indicator. This invention is designed to enhance the accuracy and safety of vascular access procedures. The patent reflects his commitment to advancing medical technology and improving healthcare practices.

Career Highlights

Eli Matalon is currently associated with Vascular Technologies, Inc. His role in the company allows him to apply his innovative ideas in a practical setting. His contributions have been instrumental in developing new technologies that address critical needs in the medical field.

Collaborations

Due to space constraints, the collaborations section will be omitted.

Conclusion

Eli Matalon is a dedicated inventor whose work in vascular technology has the potential to transform medical practices. His innovative spirit and commitment to improving patient care are evident in his contributions to the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…